baber/WOPTO huggingface dataset:
Patent NZ-533170-A (NZ)
Title: A peptide-based fluorescence polarization assay for detection of antibodies to Mycobacterium bovis
Inventor: SURUJBALLI OM P
IPC: G01N33/569
Filed: 2002-10-31
Abstract: A method for detecting Mycobacterium bovis-infected animals comprises: adding a tracer to a sample from an animal to form a mixture, wherein the tracer is formed by labelling a polypeptide of M. bovis protein MPB70 with a fluorophore, wherein the polypeptide has more than 10 but less than 100 amino acids; measuring the fluorescence polarization of the mixture; and detecting the presence of M. bovis antibodies in the animal from the measured fluorescence polarization of the mixture. Also described is a tracer for detecting M. bovis antibodies in a fluorescence polarization assay, wherein the tracer is formed by labelling a polypeptide of M. bovis protein MPB70 with a fluorophore, wherein the polypeptide has more than 10 but less than 100 amino acids, such that the tracer binds to antibodies specific for M. bovis to produce a detectable change in fluorescence polarization.
Patent NZ-535859-A (NZ)
Title: Planing landing craft
Inventor: MALONEY KEN
IPC: B63B1/20
Filed: 2003-03-14
Abstract: An improved landing craft, includes a hull (11) that supports bow (19) and stern ramps (20) for enabling vehicles to drive through during loading and unloading. The drive-through arrangement also enables the crew to load and unload the craft much faster and more easily than existing vessels. A ballasting arrangement can be used to trim the hull when it is to be beached or to be extracted and/or during loading/unloading.
Patent NZ-538959-A (NZ)
Title: Method and system of securely escrowing private keys in a public key infrastructure
Inventor: ANDREWS RICHARD F
IPC: H04L9/08
Filed: 2003-09-02
Abstract: A system for escrowing a private key in a public key infrastructure has a secondary site, coupled to the network, including a secondary database and a control centre and a primary site, coupled to a network, including a primary database and a key management server. The primary site is adapted to create a key pair including a private key and a public key, create a session key, encrypt the private key using the session key, create a session key mask, store the encrypted private key and the session key mask in the primary database, create a masked session key by exclusive-ORing the session key and the session key mask, delete the session key, and send the masked session key and a digital certificate to the secondary site for storage within the secondary database.
Patent NZ-540204-A (NZ)
Title: Pipe scarifier for cleaning inside of sewer pipe with nozzles movable along vertically movable carriage between end frames
Inventor: MACNEIL GERARD J
IPC: E03F9/00
Filed: 2003-11-25
Abstract: A scarifier is disclosed for scarifying an interior wall of a sewer pipe, which includes an elongated frame having spaced apart upstanding frame elements at either end forming a plurality of guide surfaces on each side. A first track extends from one end of the frame to another, reversibly moveable upwardly along a first set of the guide surfaces on a first side of the frame in response to a control signal, which controls a drive system coupled to the track. A nozzle assembly is reversibly moveable along the track from one end of the scarifier to another so that a nozzle, mounted on the nozzle assembly, which emits a jet of fluid towards an interior surface of the sewer pipe, is operative to scarify a swath along the interior surface.
Patent NZ-540614-A (NZ)
Title: Concrete mesh lifter
Inventor: WITTEMAN RICHARD HUBERTUS
Filed: 2005-06-07
Abstract: A concrete mesh chair placement bar (10). The bar comprises a walking-stick-shaped lever formed from a solid metal rod (11) including a handle (16) and a lifting end. The lifting end is formed at a 180 degree bend in the rod at an end opposite the handle, and includes an outwardly extending round head bolt (12) rigidly secured to the rod, the head bolt being adapted for engaging strands of wire mesh and the like. Two flat mounting straps (13) are rigidly fixed below the round head bolt.
Patent NZ-541923-A (NZ)
Title: Roll forming apparatus for forming sheet material into multiple shapes
Inventor: BARNES BENJAMIN A
IPC: B21D5/08
Filed: 2004-02-25
Abstract: A sheet 16 roll former is provided with fixed leg former rollers 106 and opposite different configuration leg rollers 114 and 116 mounted on pivotable support plates 110 so that one or the other of the different configuration rollers can be toggled into engagement with the sheet edge depending on the configuration into which the leg is to be rolled.
Patent NZ-545928-A (NZ)
Title: Methods and device for the preparation of a drink by injecting a liquid into an enclosure containing a soluble food substance
Inventor: DENISART JEAN-PAUL
IPC: A47J31/06
Filed: 2004-08-13
Abstract: A method for preparing a beverage by injecting jets J of fluid to an enclosure containing a soluble food substance 4. The fluid injection points 42 are away from the central axis A of the enclosure, and the jets J of fluid travel away from the central axis A. The jets J of fluid travel perpendicular to the central axis A of the enclosure and at angles to the transverse plane of the enclosure. This produces a swirling movement about the centre of the enclosure mixing the fluid with the soluble food substance. The method produces drinks with a constant concentration.
Patent NZ-546612-A (NZ)
Title: Process for the production of 6,7-dihydroxy steroid compounds by allylic oxidation of steroid-5-ene compounds to steroid-5-ene-7-one compounds followed by hydroboration and oxidation intermediates of this process
Inventor: BURGOYNE DAVID L
IPC: C07J41/00
Filed: 2002-05-22
Abstract: A method for the production of 6,7-dihydroxy steroid compounds by allylic oxidation is disclosed, wherein the method for allylic oxidation comprised the steps of: (a) providing a compound comprising a steroid carbon skeleton and two geminal allylic hydrogens as present in formula (1); (b) contacting the compound with reagents comprising an oxidizing agent (such as copper iodide and t-butyl hydroperoxide) and an amine (such as pyridine) to provide a mixture; and (c) maintaining the mixture of step (b) under oxidizing conditions to convert the compound to a product having a carbon skeleton and an a,a-unsaturated ketone moiety as present in formula (4).
Patent NZ-547939-A (NZ)
Title: Push to watch: a video person-to-person streaming application
Inventor: DE FINA SILVIA
IPC: H04N7/173
Filed: 2004-12-14
Abstract: A method of providing interactive video streaming in a mobile communication network between two items of equipment connected to the network, at least one of which is a user terminal, is disclosed. The method includes the steps of (a) establishing a communication session between the items of equipment in the IP multimedia subsystems (IMS) domain of the mobile network, (b) setting up a packet switched communication channel using session initiation protocol (SIP) between the items of equipment, and (c) enabling one of the items of equipment to stream video to the other as required from time to time. The video streaming is enabled in only one direction at any one time.
Patent NZ-550267-A (NZ)
Title: Tetrahydronaphthyridine derivatives as cholesteryl ester transfer protein inhibitors
Inventor: KUBOTA HITOSHI
IPC: A61K31/4375
Filed: 2005-04-01
Abstract: Disclosed are tetrahydronaphthyridine derivatives of formula (I) wherein the substituents are as described in the specification and methods of producing them. The compounds of the invention are cholesteryl ester transfer protein (CETP) inhibitors useful in the treatment of arteriosclerosis, peripheral vascular disease, dyslipidemia, hyperbetalipoproteinemia, hypoalphalipoproteinemia, hypercholesterolemia, hypertriglyceridemia, familial-hypercholesterolemia, cardiovascular diseases, angina, ischemia, cardiac ischemia, stroke, myocardial infarction, reperfusion injury, restenosis after angioplasty, hypertension, cerebral infarction, cerebral stroke, diabetes, vascular complication of diabetes, thrombotic diseases, obesity and endotoxemia.
Patent NZ-553791-A (NZ)
Title: Stoppered discharge valve for cistern
Inventor: ER OSMAN
Filed: 2005-10-11
Abstract: A stoppered discharge system A mounted on toilet reservoirs and used for discharging of any amount of water desired by the user, which comprises: a discharge bearing 1 which is fixed to exit channel of reservoir from cylindrical region hereon and to lower interior surface of reservoir from rabbetted sitting surface and has two gasket channels in cylindrical region ; sealing gaskets 2 which are fixed to the gasket channels ; a lantern 3 having a body in a hollow cylindrical form in which a discharge tube 4, comprising a styrofoam clip 9, a styrofoam 10, a segment 11, a discharge gasket 12 and a styrofoam lower plate 13, is located; a discharge tube 4 having a hollow cylindrical form wherein its upper and lower surfaces are opened, two finger engagement recesses are located on upper side hereof to attach pull arm finger , a segment gasket sitting surface formed by diameter attenuation at lower side hereof where two segments 11 and discharge gasket 12 in between are placed top of each other; a pull arm connection part 16 attached to pull arm 5; a styrofoam 10 having a cylindrical structure wherein discharge tube engagement opening is located throughout in the middle; a discharge bearing support 8 having a body in flat elongated plate form; characterized in that the discharge bearing 1 comprises a support channel in form of a track or channel which abuts to back interior surface of reservoir and in which discharge bearing support 8 engages to prevent discharge bearing 1 from rotating in an uncontrolled way and a front flat region abutting front interior surface of reservoir and extending as directly opposed to support channel ; a bearing locks at both sides of discharge bearing 1 used to fix the position of lantern 3 and to be engaged with lantern fingers belonging to lantern 3; a finger engagement space extending on the support channel in which discharge bearing support finger is attached; a styrofoam lower plate sitting surface extending on the discharge bearing 1 on which styrofoam lower plate 13 is located.
Patent NZ-554112-A (NZ)
Title: Poker blackjack game
Inventor: SORGE NICHOLAS
IPC: A63F1/00
Filed: 2005-09-22
Abstract: An apparatus for playing a modified blackjack game between at least one player and a dealer is disclosed. The apparatus comprises a playing surface having a first wager zone and an additional wager zone disposed in the vicinity of each player, one or more standard decks of playing cards, and one or more wagering devices. At least one player places a first wager by placing at least one wagering device in their first wager zone to participate in the blackjack game and an outcome of the first wager is determined by conventional rules of blackjack play. At least one player places an additional wager by placing one or more wagering devices in their additional wager zone, and the additional wager corresponds to a five-card poker hand comprising an initial hand of two cards dealt to any player placing an additional wager and three cards dealt as community cards. A first card is dealt to each player and to the dealer, then a second card is dealt to each player, then three community cards are dealt, which in combination with the two cards dealt to any player placing an additional wager, comprise the five-card poker hand. A rank is determined of the five-card poker hand of the player placing the additional wager and a predetermined multiple of an amount of the additional wager is paid or collected based on the rank of the five-card poker hand. A second card is dealt to the dealer and the blackjack game is completed according to conventional rules of blackjack play.
Patent NZ-561939-A (NZ)
Title: Alkynyl pyrrolopyrimidines and related analogs as HSP90-inhibitors
Inventor: KASIBHATLA SRINIVAS R
IPC: A61K31/497
Filed: 2006-03-29
Abstract: Alkynyl pyrrolo[2,3-d]pyrimidines of formula (I) and related analogs are disclosed and demonstrated to have utility as Heat Shock Protein 90 (HSP90) inhibiting agents used in the treatment and prevention of various HSP90 mediated disorders or HSP90-dependent diseases and conditions selected from the group consisting of cancer and fibrogenic disorders selected from the group consisting of scleroderma, polymyositis, systemic lupus, rheumatoid arthritis, liver cirrhosis, keloid formation, interstitial nephritis, and pulmonary fibrosis. Methods of synthesis and use of these alkynyl pyrrolo[2,3-d]pyrimidine compounds are also disclosed.
Patent NZ-572001-A (NZ)
Title: Treatment of poultry for increasing the feed conversion rate or for reducing the incidence of ascites by administration of dialkyl glycine derivatives
Inventor: JANSSENS GEERT
IPC: A61K31/198
Filed: 2006-03-21
Abstract: Disclosed is a method for the treatment of poultry for the purpose of reducing the conversion rate of the feed used to raise the poultry, which treatment comprises orally administering at least one glycine compound of formula (I) (or a salt thereof) to the poultry, wherein: R1 and R2 are independently alkyl, alkenyl or a hydroxyalkyl radical containing 1 to 18 carbon atoms or wherein R1 and R2 form jointly together with the N atom a heterocyclic 5- or 6-membered ring; the compounds of formula (I) which are N,N-dimethylglycine (DMG), N,N-diethylglycine, N,N-diethanolglycine, N,N-dipropylglycine and N,N-diisopropylglycine being particularly relevant. Also disclosed is the use of a glycine compound as defined above and/or a salt thereof for reducing the incidence of ascites in poultry.
Patent NZ-572918-A (NZ)
Title: Crystalline duloxetine hydrochloride crystallised from toluene and ethanol
Inventor: JIANG WEI PING
IPC: C07D333/16
Filed: 2007-06-21
Abstract: Disclosed is crystalline duloxetine hydrochloride which is prepared by: (a) dissolving duloxetine in toluene to form a first solution; (b) combining the first solution with a second organic solvent comprising ethanol and HCI to form a second solution; (c) allowing duloxetine hydrochloride to crystallise out from the solution during a period of cooling at 0°C to 10°C; and (d) collecting the crystallised duloxetine hydrochloride, wherein said crystalline duloxetine hydrochloride exhibits an X-ray diffraction pattern comprising peaks expressed in degrees two-theta at 11.99 ± 0.2, 14.78 ± 0.2, 21.44 ± 0.2, 22.16 ± 0.2, 23.12 ± 0.2 and 24.12 ± 0.2.
Patent NZ-585778-A (NZ)
Title: Motor drive mechanism for an electronic deadbolt lock including a spring and coupler to attach the spring to the motor output shaft
Inventor: BOGDANOV VICTOR
IPC: E05B9/02
Filed: 2008-10-31
Abstract: Disclosed is a motor drive mechanism particularly for an electronic deadbolt lock. The mechanism includes a motor (265) that has a rotatable output shaft (280) extending outward from the motor and defining a rotational axis. The mechanism also includes a coupler (270) that is coupled to the output shaft for rotation therewith, and a coil spring (275) that is coupled to the coupler without external attachment means. The coupler includes a spring receiving portion (300) with a recess, the spring extending into the recess such that rotation of the coupler is transferred to the coil spring.
Patent NZ-593585-A (NZ)
Title: Crystalline forms of vorinostat (suberoylanilide hydroxamic acid)
Inventor: GORE VINAYAK
IPC: C07C239/14
Filed: 2009-11-25
Abstract: Disclosed is a crystalline form VI of vorinostat (also known as N-hydroxy-N'-phenyl-octanediamide or suberoylanilide hydroxamic acid (SAHA)), characterised by an XRPD spectrum comprising fourteen or more of the following degrees 2[theta] peaks: 5.01, 7.50, 9.23, 9.92, 10.51, 12.46, 14.90, 17.32, 19.35, 19.86, 22.36, 23.85, 24.20, 24.74, 25.81, 26.93, 27.85 plus or minus 0.2 degrees 2[theta]. Also disclosed is a process for the preparation of crystalline vorinostat form III, comprising: (a) mixing vorinostat form VI in ethanol and aqueous ammonia; and (b) isolating the vorinostat form III formed.
Patent NZ-593860-A (NZ)
Title: Side illuminated multi point multi parameter optical fiber sensor
Inventor: EGALON CLAUDIO OLIVEIRA
IPC: G01F23/292
Filed: 2010-02-01
Abstract: 593860 Disclosed is a system for sensing properties of a substance using an optical fibre. The system is comprised of a sensitive optical fibre (98), a detector (108) optically coupled to one end of the optical fibre (98), and a signal processor (110) in data communication with the detector (108). The optical fibre (98) has first and second ends and a core (106). The core (106) has at least one exposed, cladding-free core region (92) along the fibre (98) between the first and second ends. The signal processor (110) is configured to determine the degree of a property of a substance (93) operatively optically coupled with the at least one exposed region (92) upon a stimulation of the substance (93) by transverse probing light (from source 100). The transverse probing light does not substantially travel axially along the fibre (98) to reach the substance (93). The substance (93) has a property of chemiluminescence, phosphorescence, fluorescence, or scattering, refraction, reflection or absorption of light. The determination results from a correlation of light intensity over a predetermined range of wavelengths.
Patent NZ-596362-A (NZ)
Title: Therapeutic agent for motor disorders
Inventor: KANDA TOMOYUKI
IPC: A61K31/435
Filed: 2010-04-28
Abstract: 596362 Disclosed herein are a therapeutic and/or prophylactic agent for a motor disorder, which comprises a thiazole derivative represented by general formula (I) (wherein R1 represents an aryl group or the like; and R2 represents a pyridyl group or the like) or a pharmaceutically acceptable salt thereof as an active ingredient; the therapeutic and/or prophylactic agent, wherein the motor disorder is extrapyramidal syndrome; the therapeutic and/or prophylactic agent, wherein the motor disorder is bradykinesia, gait disturbance, dystonia, dyskinesia or tardive dyskinesia; the therapeutic and/or prophylactic agent, wherein the motor disorder is an adverse side effect of an L-dopa and/or dopamine agonist therapy; and others.
Patent NZ-601661-A (NZ)
Title: Compositions and methods for treating viral diseases
Inventor: HUBERMAN ELIEZER
IPC: A61K31/407
Filed: 2011-02-25
Abstract: Substituted perhydro pyrrolopyridines and methods for their use in the treatment of viral diseases including hepatitis C viral infections are described herein.
Patent NZ-602079-A (NZ)
Title: Components for rail fastening assembly
Inventor: COX STEPHEN JOHN
IPC: E01B9/00
Filed: 2007-07-04
Abstract: 602079 Disclosed is a sealing plate (2) for use with a railway fastening system apparatus. The apparatus which the sealing plate (2) is intended for use with has a rail clip anchoring device with a stem extending from a head thereof for retaining the anchoring device in a concrete sleeper when the anchoring device is in use. The plate (2) comprises locating means (27) for locating the plate (2) on the head of the anchoring device, whereby the plate (2) is positioned so as to extend over the underside of the head when the stem of the device is being set in a concrete sleeper, thereby to prevent ingress of concrete into the head of the device. The plate (2) is adapted so as to be retained on the surface of the sleeper thereafter and provide a flat bearing surface for receiving a component plate of the apparatus. The locating means comprise at least one tab (27) protruding from a major face (20) of the plate (2) for engaging with a corresponding feature on the anchoring device.
Patent NZ-602420-A (NZ)
Title: Method and apparatus for applying plasma particles to a liquid and use for disinfecting water
Inventor: ZOLEZZI-GARRETON ALFREDO
IPC: H05H1/00
Filed: 2011-02-09
Abstract: Disclosed is a method of applying plasma particles to a liquid comprising the steps of: obtaining a first stream of liquid; obtaining a biphasic mixture having a gas portion and a liquid portion from said first stream of liquid by passing said first stream through an atomizer into a reactor providing an expanding volume, wherein pressure within said reactor is lower than vapour pressure of said first stream at local temperature resulting in an abrupt adiabatic phase change in said first stream, thereby producing said biphasic mixture from said first stream; igniting a plasma state in said gas portion of said biphasic mixture; and obtaining a second stream of liquid by condensing said biphasic mixture and returning it to a liquid state following said igniting of said plasma state. Also disclosed is a method for sanitizing water comprising the steps of: obtaining a biphasic stream from water, the biphasic stream having a gas portion and a liquid portion, comprising feeding said water at the ingress of a reactor providing an expanding volume through an atomizer, wherein pressure within said reactor is lower than vapour pressure of said water at local temperature resulting in an abrupt adiabatic phase change in said water, thereby producing said biphasic stream from said water; igniting a plasma state in said biphasic stream inside said reactor by applying an electric discharge; and condensing said biphasic stream and returning it to a liquid phase at the egress of said reactor. Additional an apparatus is also disclosed comprising; a liquid feedstock input means further comprising at least one pump and at least one high-pressure pipe; an atomizer and a reactor providing an expanding volume for said liquid feedstock, wherein pressure within said reactor is lower than vapour pressure of said liquid feedstock at local temperature resulting in an abrupt adiabatic phase change in said liquid feedstock, thereby producing a biphasic mixture from the liquid feedstock, wherein said biphasic mixture has a portion of liquid droplets and a portion of gas; the reactor further having a pair of electrodes for igniting a plasma state in said gas portion of said biphasic mixture; and a liquid condenser for returning said biphasic mixture to a liquid state following said igniting of said plasma state.
Patent NZ-603713-A (NZ)
Title: Recombinant host cells comprising phosphoketolases
Inventor: DAUNER MICHAEL
IPC: C12N15/63
Filed: 2011-06-16
Abstract: Disclosed is a recombinant non-human host cell comprising: (i) at least one deletion, mutation, or substitution, or combinations thereof, in an endogenous gene encoding a polypeptide having pyruvate decarboxylase activity, wherein the at least one deletion, mutation, and/or substitution results in pyruvate decarboxylase activity that is reduced or eliminated; and (ii) a heterologous polynucleotide encoding a polypeptide having phosphoketolase activity.
Patent NZ-605758-A (NZ)
Title: Hybrid light chain mice
Inventor: MACDONALD LYNN
IPC: A01K67/027
Filed: 2011-06-22
Abstract: Genetically modified mice are provided that express human λ variable (hVλ) sequences, including mice that express hVλ sequences from an endogenous mouse λ light chain locus, mice that express hVλ sequences from an endogenous mouse κ light chain locus, and mice that express hVX sequences from a transgene or an episome wherein the hVλ, sequence is linked to a mouse constant sequence. Mice are provided that are a source of somatically mutated human λ variable sequences useful for making antigen- binding proteins. Compositions and methods for making antigen-binding proteins that comprise human λ variable sequences, including human antibodies, are provided.
Patent NZ-608443-A (NZ)
Title: Programmable multimedia controller with flexible user access and shared device configurations
Inventor: LOCASCIO TIMOTHY R
IPC: H04N21/475
Filed: 2011-09-22
Abstract: A system which includes a programmable multimedia controller is provided in which flexible user access is provided through a combination of user profiles and usernames/passwords. A configuration for a given device which may form part of the system or may interoperate with the system may be shared by multiple similar devices. A sharable device configuration is stored by a master device and can be shared by other devices of the same type as the master device.